Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases by Harvey, P et al.
Malignant mesothelioma (MM) is an aggressive cancer arising
from the serosal cells of the pleural cavity and is frequently associ-
ated with occupational asbestos exposure (Reviewed Attanoos and
Gibbs, 1997). Although MM is not a common disease at present,
epidemiological statistics predict that its occurrence will rise
continuously in the UK for at least the next 20 years (Peto et al,
1995). MM is also resistant to conventional therapy and the
median life-span post-diagnosis is less than 9 months. Therefore, a
better understanding of the fundamental biology of MM is needed
to develop new forms of treatments.
Experimental and clinical investigations have revealed that
aberrant hepatocyte growth factor/scatter factor (HGF/SF)-Met
signalling very likely contributes to the growth and progression of
many types of neoplasms including carcinomas (Prat et al, 1991),
sarcomas (Rong et al, 1993), and gliomas (Moriyama et al, 1996).
HGF/SF is a heterodimeric molecule composed of 69 kDa and 
34 kDa subunits. It is synthesized as a single-chain inactive pre-
cursor and cleaved into the active form by extracellular urokinase and
other serine-proteases (Naldini et al, 1992; Miyazawa et al, 1993).
The factor is considered to be produced usually by mesenchymal-
derived cells, acting in a paracrine manner on a wide variety of
epithelial cell types (Stoker et al, 1987; Sonnenberg et al, 1993). In
addition, the co-expression of Met and HGF/SF in the same cell
creates an autocrine loop that is oncogenic (Rong et al, 1992;
Jeffers et al, 1996a). The HGF/SF receptor Met is a tyrosine kinase
receptor encoded by the proto-oncogene c-met and is often over-
expressed in human cancers (Di Renzo et al, 1991; Prat et al,
1991). The receptor is a heterodimer of covalently linked alpha
and beta chains of 45 and 145 kDa respectively, with a multi-
functional docking-site motif (Bottaro et al, 1991; Naldini et al,
1991). HGF/SF-Met signalling regulates several major biological
processes stimulating cell proliferation (Gherardi et al, 1993),
motility (Stoker et al, 1987; Sonnenberg et al, 1993) and invasion
into extracellular matrices (Weidner et al, 1990). Moreover, dereg-
ulated HGF/SF-Met signalling has been shown to enhance in vivo
metastatic potential of various cell types (Jeffers et al, 1996a;
Rong et al, 1994; Rosen et al, 1994). HGF/SF is also a potent
inducer of angiogenesis (Bussolino et al, 1992; Grant et al, 1993).
In a previous study, over 90% of patients with malignant
mesothelioma or primary lung cancers contained increased
amounts of HGF/SF in their pleural effusion fluids (Eagles et al,
1996). Immunochemical studies showed strong reactivity for
HGF/SF and Met in sections of tumours taken from patients with
mesothelioma (Harvey et al, 1996, Thirkettle et al, 2000). Initial
work on human mesothelioma cell lines (HMCL) demonstrated
that some cell lines secreted HGF/SF (Harvey et al, 1998).
Comparison of an epithelioid cell line (BT) with a fibroblastoid
cell line (BR) suggested two major differences in their responses
to HGF/SF. BT cells showed significantly enhanced mitogenesis
in response to HGF/SF but BR did not. Furthermore, the BR cell
line showed reduced cell contacts and enhanced cell motility in the
presence of the factor, whereas BT cells showed increased
spreading but did not rupture cell–cell contacts. In this study, the
cell lines BT and BR previously described in Harvey et al (1998),
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doi: 10.1054/ bjoc.2000.1445, available online at http://www.idealibrary.com on and an additional cell line, TA, with a mixed phenotype, were
further tested, particularly for their ability to invade Matrigel, a
reconstituted basement membrane.
The breakdown of extracellular matrix (ECM) necessary for
invasion is partly controlled by the proteolytic activity of zinc-
dependent matrix metalloproteinases (MMPs) (Reviewed Murphy
and Knäuper, 1997). The MMP family is implicated in a variety of
normal and pathological processes including tumorigenesis and
comprises at least 20 members with different and overlapping
substrate specificity (Johnson et al, 1998). They are tightly regu-
lated by the tissue inhibitors of metalloproteinases (TIMPs). The
expression of MMPs and TIMPs can be modulated by growth
factors and cytokines. For instance, it has been reported that
HGF/SF increased the expression of collagenase 1 (MMP-1) and
stromelysin-1 (MMP-3) in keratinocytes (Dunsmore et al, 1996),
and MT1-MMP and MMP-2 in glioma cells (Hamasuna et al,
1999). To our knowledge, the expression of MMPs and TIMPs in
malignant mesothelioma (MM) has not been described yet.
Therefore, the cell lines were analysed for the expression of some
MMPs including gelatinases A and B (MMP-2 and MMP-9),
MT1-MMP (MMP-14), stromelysin 1 (MMP-3), and collagenase
1 (MMP-1) thought to play an important role in tumourigenesis
and the MMP inhibitors TIMP-1 and TIMP-2 (Reviewed
Coussens and Werb, 1996). An attempt was made to correlate
MMP and TIMP expression patterns with cell behaviour and
HGF/SF effects.
MATERIALS AND METHODS
Cell lines and growth factor
The human mesothelioma cell lines were grown in RPMI 1640
medium (Gibco BRL, Paisley, UK) containing 10% foetal calf
serum (FCS), at 37° C in a 5% CO2 atmosphere (Zeng et al, 1994a).
Three HMCL were chosen covering the MM phenotypes: BT, cell
line of epithelioid type, BR cells that have a fibroblastoid pheno-
type, and TA cells with a mixed phenotype. Sub-confluent cell
cultures were used for all experiments which were all performed at
least three times with similar results and representative data are
shown. Recombinant human HGF/SF was produced in Sf21 insect
cells using the baculovirus expression system and, after purifica-
tion, was judged > 95% pure, as seen by gel electrophoresis and
Western blotting (Newman and Warn, unpublished).
Cell migration assay
The effects of the growth factor on cell migration were assessed as
previously published (Peacock et al, 1992), using a 48-well micro-
chemotaxis chamber (Corning Costar, High Wycombe, UK) and 
8-µ m pore polycarbonate PVP-free filters (Corning Costar),
precoated with 5 µ g ml–1 of gelatin to facilitate cell attachment.
The HMCL were used at a concentration of 5 × 105 cells ml–1 in
0.5% FCS-medium and left to migrate for 4.5–9 h at 37° C. After
incubation, the filters were fixed in methanol and the cells stained
using a Pro-Diff staining kit (Braidwood Labs, UK). Cells on the
upper face of the filters were removed by gentle scraping, the
filters further washed in phosphate-buffered saline (PBS) and
mounted onto microscope slides. Cell migration was quantified by
counting the cells which moved through the pores using a Zeiss
Standard R microscope (× 160); two fields per well were selected,
each sample being repeated with six wells. The chemotactic effect
of HGF/SF was investigated by adding the factor in the bottom
chamber at different concentrations. The migration of TA cells
was also challenged in the presence of neutralizing HGF/SF anti-
body (R & D Systems, Abingdon, UK) and suramin, a gift from
Bayer AG (Wuppertal, Germany).
Cell adhesion assay
The HMCL were grown to 80% confluency and transferred in
0.5% FCS medium. Half of the cultures were exposed to HGF/SF
(10 ng ml–1) 24 h prior to the adhesion assay. The adhesion
assays were performed as described in Messent et al (1998).
Briefly, 96-well plates (Corning Costard) were coated with 50 µ l
of Matrigel (Becton Dickinson-Stratech, Luton, UK) at various
concentrations, then washed and blocked with 1% heat-
denatured BSA in PBS. The HMCL were trypsinized,
centrifuged and resuspended in 0.5% FCS medium. 5 × 104 cells
were loaded per well in triplicates and left to adhere for 40 min at
37° C. The plates were then rinsed twice with PBS and the
attached cells fixed and stained with 1% Methylene Blue in 0.01
M borate for 30 min. Excess dye was washed off with water and
lysis solution with ethanol and 0.1 M HCl (1:1) was added to the
wells. The absorbance of the released dye was measured at 630
nm using a spectrophotometer.
Matrigel invasion assay
To assess the invasion capacity of the HMCL, transwell chambers
with 8-µ m pore polycarbonate filters (Becton Dickinson-Stratech)
were coated with Matrigel diluted in serum-free medium at
approximately 200 µ g cm–2. Cells were collected from subcon-
fluent cultures and used at a concentration of 105 cells ml–1 in 0.5%
FCS medium. The wells were filled with 750 µ l of 0.5% FCS-
medium with or without HGF/SF (10 ng ml–1) and the chambers
were seeded with 400 µ l of cell suspension. The effects of the
MMP inhibitor CT1746 (Celltech Pharmaceuticals, Slough, UK)
and the serine proteinase inhibitor aprotinin (Sigma, Poole, UK)
were tested by adding them to the pre-coated chambers 1 h prior to
the cells. After 24 h migration, the cells still in the chamber were
removed using a cotton swab and the migrated cells fixed and
stained as for the chemotaxis assay. When dried, the filters were
cut free with a razor blade, mounted in DePeX (BDH) and the cells
counted as above; six fields per filter were selected for cell counts
and the experiments repeated three times.
MMP and TIMP expressions
Conditioned media and cell lysates
The HMCL were grown on plastic or Matrigel-coated plates in an
attempt to correlate better the expression of MMPs and TIMPs with
the Matrigel invasion assays. Subconfluent cells were serum-starved
in 0.5% FCS-RPMI overnight and then left for 48 h in 0.5%
FCS medium and exposed to a range of HGF/SF concentrations.
Conditioned media were collected, clarified and stored at –80° C.
The cells were trypsinized and resuspended in lysis buffer containing
50 mM Tris-HCl pH 8, 150 mM NaCl, 10 mM CaCl2, 1% Triton-
100, 10 µ g ml–1 of Aprotinin, 1 µ g ml–1 of Pepstatin A, Leupeptin
and E64 (Sigma) (Lohi et al, 1996). Cell lysates were transferred in
Eppendorf tubes, left on ice for 20 min and centrifuged at 15 000 g
for 20 min. The supernatants were collected and protein concentra-
tions determined by the BCA protein assay (Pierce IL, USA).
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Equal amounts of protein lysates were loaded on a 10% polyacryl-
amide gel and transferred onto nitrocellulose membrane ECL-
Hybond (Amersham, UK) for the detection of MT1-MMP and 
the expression of stromelysin-1 was analysed using equivalent
volumes of conditioned media determined from the protein
concentration of the cell lysates. Blots were probed with sheep
anti-human MT1-MMP (D’Ortho et al, 1998) or MMP-3 protein
antibodies (Allan et al, 1991) (gifts from Professor Gillian
Murphy, UEA, Norwich, UK) and with HRP-conjugated donkey
anti-sheep (Jackson-Stratech, Luton, UK). Detection was carried
out using the enhanced chemiluminescence system (Amersham).
Gelatin zymography
MMP-2 and MMP-9 were detected by gelatin zymography as
described by Edwards et al (1996). Samples were run under non-
reducing conditions on 10% polyacrylamide gels containing 
1 mg ml–1 of gelatin (Sigma). After electrophoresis, the gels were
rinsed twice in 2.5% Triton X-100, then incubated in 50 mM 
Tris-HCl buffer pH 7.5 with 5 mM CaCl2 for 24 h at 37° C. The
gels were then stained with Coomassie blue, then de-stained until
the light bands demonstrating the MMP activities were visible
against the dark blue background.
Reverse zymography
TIMP-1 and TIMP-2 released in cell conditioned media were
detected by reverse zymography (Edwards et al, 1996). The gels
and samples were prepared and treated as for zymograms but with
the addition of a solution containing gelatinase activity mixed in
12% polyacrylamide gels. As a result, the TIMPs appeared as dark
blue bands where the gelatin degradation was prevented. Band
intensities of Western blots and zymograms were further measured
using Gelwork 1D Image Analysis for Windows.
ELISAs
MMP-1 and TIMP-1 were quantified by double sandwich ELISA as
published by Clark et al (1992). Nunc 96-well plates (Gibco BRL)
were coated with 2 µ g ml–1 of monoclonal mouse anti-human MMP-
1 or anti-human TIMP-1 (RRU series antibodies) overnight at 4° C.
The microplates were then blocked with 10 mg ml–1 BSA (Sigma) in
PBS for 30 min at room temperature and washed in PBS, 0.1%
Tween 20. The standard range of MMP-1 and TIMP-1 concentra-
tions were prepared in wash buffer containing 0.5 mg ml–1 BSA.
Conditioned media for MMP-1 detection were added neat to the
plates, in duplicates, while the detection of TIMP-1 required a 1:20
dilution of the media. The plates were incubated for 2 h at room
temperature and those containing neat media were kept in a CO2
chamber to maintain the pH neutral. The plates were washed three
times between each step in PBS-Tween. Biotinylated anti-MMP-1 or
anti-TIMP-1 antibodies were then incubated for 2 h, followed by the
complex streptavidin-HRP (Dako, Cambridge, UK) for 30 min. The
OPD tablet substrate (Sigma) was dissolved in phosphate-citrate
buffer (Sigma) and added to the plates. The incubations were carried
out at room temperature in the dark until the colour was satisfactory.
The reactions were stopped with 2 M H2SO4solution and absorbance
was read at 490 nm.
RESULTS
HGF/SF enhanced the motility of HMCL
The three HMCL showed enhanced motility in a dose-dependent
response to HGF/SF but with some variation (Figure 1A). The
factor increased the motility of the mixed-phenotype TA cell line
five-fold while a weaker but significant effect was obtained in the
fibroblastoid BR cells. A maximum HGF/SF response was usually
seen around low concentrations of 2–5 ng ml–1, levels previously
observed ex vivo in pleural effusion fluids (Eagles et al, 1996). In
contrast, the motility of the epithelial cell line BT rose over the
whole range of HGF/SF concentrations, but the BT cells needed a
longer time to migrate (Figure 1A). The addition of neutralizing
anti-HGF/SF antibodies to exogenous HGF/SF strongly reduced
the cell motility as shown with the TA cell line (Figure 1B).
Suramin, a drug which inhibits tyrosine kinase receptor activation
and is less specific to HGF/SF – Met signalling also blocked the
cell migration stimulation (Figure 1B).
HGF/SF enhanced the HMCL adhesion onto Matrigel
HGF/SF facilitated the adhesion of the three cell lines onto
Matrigel (Figure 2). The Matrigel strongly increased the attach-
ment of all cell lines. At a low density of Matrigel (25 µ g cm–2), it
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suraminappeared that the mixed-phenotype TA cells adhered better than
the epithelioid BT and the fibroblastoid BR cells (Figure 2). With
increased Matrigel coating, the cell adhesion started to plateau but
the HGF/SF 24-h pre-treatment enhanced the adhesion of the three
cell lines and particularly of the TA and BR cells.
HGF/SF enhanced the invasion of HMCL into Matrigel
BR and TA cells were highly invasive as judged by 24-h Matrigel
invasion assays, whereas the most epithelioid cell line did not
migrate through the Matrigel even during assays lasting for 48 h
(Figure 3A). The addition of HGF/SF markedly stimulated all the
cell lines to invade, the strongest effects being observed with TA
cells. The epithelioid BT cells became weakly invasive in the pres-
ence of the factor after 48 h. TA cell invasion into Matrigel was
reduced by proteinase inhibitors in a dose-dependent manner
(Figure 3B); the serine protease inhibitor aprotinin was more effi-
cient in decreasing invasion than the synthetic hydroxamate MMP
inhibitors CT1746.
Expression of some MMPs and TIMPs in the HMCL, and
their regulation by HGF/SF
Gelatin zymograms and reverse zymograms were run loading
equivalent volumes of conditioned media determined from the
protein concentration of the cell lysates. All three cell lines
expressed both MMP-2 and MMP-9, which were mainly detected
as their latent forms (Figure 4). The TA cell line expressed much
more MMP-2 than MMP-9 while BT and BR cells expressed more
MMP-9. HGF/SF exposure had a weak but consistent stimulatory
effect on MMP-9 production in BT and TA cell lines in a dose-
dependent manner: densitometric analysis showed a 50–60%
increase of MMP-9 in BT cells and 70–90% increase in TA cells.
No HGF/SF effects on MMP-9 expression were detected in the
BR cells and no effects on MMP-2 were observed for any cell
lines. Reverse zymography of HMCL-conditioned media revealed
the presence of two members of the TIMP family, TIMP-1 and
TIMP-2. The levels of TIMP-1 were higher in BR and TA cells
compared to BT cells and slightly enhanced by HGF/SF, but TIMP-
2 expression seemed equal between the three cell lines and not
affected by the factor (Figure 4). TIMP-1 expression was further
measured by ELISA, which confirmed that the mixed-phenotype
TA and fibroblastoid BR cells produced higher levels of TIMP-1
than the epithelioid BT cells (Table 1). HGF/SF had no or small
stimulatory effect on TIMP-1 expressions in all cell lines (Figure 4
and Table 1).
Expression of MMP-1 was investigated by ELISA (Table 1).
The BT cells secreted more MMP-1 than the two other cell lines
and expression was increased 4–5-fold by HGF/SF. MMP-1
expression was the lowest in TA cells and yet stimulated by the
addition of exogenous HGF/SF while the factor had no effect on
MMP-1 in BR cells.
MT1-MMP was detected in the cell lysates of all cell lines at
similar levels (Figure 5). Densitometric analysis showed that
exogenous HGF/SF increased MT1-MMP expression by 50–90%
in BT and TA cells but not in the BR cell line. The expression of
MMP-3 was detected only in the TA cell line and not in the two
other lines and it was not appreciably stimulated by HGF/SF
(Figure 5).
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We show here that HGF/SF is a potent motogenic factor for human
mesothelioma cell lines and promoted cell adhesion and invasion
into Matrigel. In addition it was observed for the first time that
HMCL expressed a panel of MMPs and that some of them,
including MMP-1, MMP-9 and MT1-MMP, were up-regulated by
HGF/SF in a dose-dependent manner.
We previously reported that HMCL expressed high levels of
Met receptor and cell lines with sarcomatoid and mixed pheno-
types such as BR and TA secreted HGF/SF suggesting an
autocrine loop for the factor (Harvey et al, 1998). Moreover,
HGF/SF-induced phosphorylation of Met on tyrosine residues was
demonstrated in BT and BR cells (Harvey et al, 1998). Met activa-
tion was also shown to occur in TA cells by immunoprecipitation
and phosphotyrosine immunoblot (data not shown). The speci-
ficity of HGF/SF effects was further confirmed by the use of
neutralizing antibodies in chemotactic assays, producing a 4-fold
reduction of cell migration.
The three HMCL described in this work displayed important
common characteristics. They all responded to exogenous
HGF/SF by increased migration, adhesion and invasion through
Matrigel. They all expressed a wide panel of the zinc-dependent
proteolytic enzymes including MMP-1, 2, 3, 9 and MT1-MMP
and their inhibitors TIMP-1 and TIMP-2. Our results confirmed 
that HGF/SF is a potent motogenic factor for cells of either the
epithelial or fibroblast phenotype. A checkerboard analysis was
performed with TA cells to show that HGF/SF stimulated both
random cell motility (chemokinesis) and chemoattraction, with,
nevertheless, a stronger chemotactic effect (data not shown).
HGF/SF also facilitated all cell lines to adhere to the Matrigel.
Furthermore, there was a good correlation between motility and
invasion results for all cell lines, suggesting that HGF/SF might
increase HMCL invasion by increasing both cell adhesion and
motility, two key steps in the invasion process. Klominek et al
(1998) also showed that HGF/SF increased HMCL motility and
adhesion to type IV collagen. One of the mechanisms by which
HGF/SF could promote adhesion and motility is the modulation of
expression of the integrin family on the cell surface. Beviglia and
Kramer (1999) showed that HGF/SF stimulated both adhesion and
motility of breast cancer cells via specific beta-1 integrins.
Similarly, HGF/SF promoted adhesion of lymphoma cells to ECM
components via α 4β 1 and α 5β 1 integrins (Weimar et al, 1997). The
mesothelioma cell lines studied by Klominek et al (1997)
displayed haptotactic and chemotactic migration to laminin and
collagen type IV that involved α 6β 1 and α 2β 1 integrins. Thus, it is
likely that β 1-containing integrins play important roles in HGF/SF-
stimulated mesothelioma cell adhesion and migration. Integrin
receptors may also function in organizing the ECM degradat-
ive machinery at the cell surface, through modulation of the pro-
duction and activation of proteinases (Messent et al, 1998;
Kheradmand et al, 1998) and potentially via direct protein interac-
tions (Murphy and Gavrilovic, 1999).
The cell lines showed interesting and revealing differences in
the levels and types of MMPs and TIMPs that they expressed,
some of which are probably related to their phenotypes. BT, an
epithelial cell line, was less invasive in comparison to the fibro-
blastoid cell lines. However, exogenous HGF/SF could up-
regulate expression of some MMPs in BT cells, especially MMP-1
and MMP-9, and BT cells produced lower levels of TIMP-1, char-
acteristics that might imply increased invasive behaviour.
However, similar characteristics were described for normal
mesothelial cells where more MMP-9 and less TIMP-1 were
expressed in differentiated epithelial cells in comparison with their
undifferentiated fibroblast counterparts (Marshall et al, 1993).
These data suggest that the level of MMP-1, MMP-9 and TIMP-1
HGF/SF effects on HMCL 1151
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Table 1 ELISA for MMP-1 and TIMP-1 expression in HMCL. Data are expressed in ng for MMP-1 and µ g for TIMP-1 per
mg of total protein of cell lysates; mean ± SD
Cell lines BT-epithelioid TA-mixed BR-fibroblastoid
MMP-1 TIMP-1 MMP-1 TIMP-1 MMP-1 TIMP-1
0 26.2 ± 0.8 0.50 ± 0.01 2.0 ± 0.9 3.40 ± 0.02 31.2 ± 0.9 0.94 ± 0.04
1 101.0 ± 5.5 0.45 ± 0.02 7.3 ± 0.2 3.92 ± 0.06 24.6 ± 3.5 1.45 ± 0.01
5 107.3 ± 2.1 0.48 ± 0.01 17.3 ± 4.5 3.06 ± 0.18 31.7 ± 0.3 1.53 ± 0.01
20 93.9 ± 1.8 0.50 ± 0.01 12.4 ± 0.8 3.66 ± 0.02 12.7 ± 6.5 1.18 ± 0.02
C1C2 0 1 5 20 0 1 5 20 0 1 5 20
BT TA BR
kDa
92
72
Pro-MMP-9
Pro-MMP-2
28
21
TIMP-1
TIMP-2
Figure 4 Gelatin zymogram and reverse zymogram analysis of HMCL.
Cells were treated with a range of HGF/SF concentration (ng ml–1) for 48 h.
C1 = positive control for MMP-2; C2=positive control for MMP-9. The 0.5%
FCS-RPMI contained low levels of gelatinases but smaller than conditioned
media (not shown)
MT1-MMP
MMP-3
56
57
C 0 1 5 20 0 1 5 20 0 1 5 20 kDa
BT TA BR
Figure 5 Western blot analysis for MT1-MMP and MMP-3 in HMCL. Cells
were treated with a range of HGF/SF concentration (ng ml–1) for 48 h. MT1-
MMP was detected in cell lysates and MMP-3 in conditioned media both
collected after 48 h HGF/SF treatmentexpression observed in mesothelial and mesothelioma epithelial
cells were probably not driving invasion. Moreover, to check if the
difference in invasive properties between TA and BT cells was
partly due to different MMP expression levels, the BT cells were
challenged to invade Matrigel in the presence of medium condi-
tioned for 48 h by TA cells (data not shown). However, the BT
cells still did not invade, suggesting that they did not take advan-
tage of the exogenous MMPs in the conditioned medium. Their
poor invasiveness was not due to the previously reported inability
of HGF/SF to rupture cell-to-cell junctions in a scratch wound
assay (Harvey et al, 1998), since for the invasion assays the cells
were in suspension to allow seeding onto the Matrigel. It was
concluded that other intrinsic characteristics of BT cells were
responsible for their poor invasiveness.
In contrast, the TA and BR cell lines with a more fibroblast-like
morphology were more invasive and motile. The 10-fold increase
of invasion of TA cells into Matrigel could not be correlated to
the up-regulated expression of any particular MMP. It seems more
likely that the invasiveness of TA cell line was the result of the
additional stimulatory effects of HGF/SF on the three key stages in
invasion: adhesion, migration and ECM degradation. Furthermore,
instead of regulating the expression level of the MMPs, it is also
conceivable that HGF/SF could influence MMP trafficking and
redistribution on the cell surface, especially for MT1-MMP, or
modulate the duration of their activity. It has been reported that
MT1-MMP must be concentrated on cell surface ‘invadopodia’ for
cell invasion (Nakahara et al, 1997). MMP-3 was detected at high
levels in TA cells when cultured in Matrigel-coated plates (but not
when cells were grown on plastic, data not shown), suggesting that
this enzyme could play an important role in the invasiveness of
this cell line. However, no effect of HGF/SF was observed on
expression of MMP-3. Interestingly, the invasive TA and BR cells
also expressed higher levels of TIMP-1 than the poorly invasive
BT cells, arguing that TIMP-1 was not a dominant inhibitor of cell
invasion. TIMP-1 and TIMP-2 may have other roles to play than
regulating the activities of MMPs. For instance, TIMP-1 and
subsequently TIMP-2 were found to promote cell growth for a
wide range of cells (Yamashita et al, 1996b). Exogenous HGF/SF
did not reduce the production of TIMP-1 as reported elsewhere
(Nakayama et al, 1993) but slightly increased it. The level of
TIMP-1 was also highest in TA and BR cells, both of which
express HGF/SF, suggesting there may be a link between HGF/SF
and TIMP-1 expression in the fibroblastoid cell types.
We were frustrated in our attempts to block invasion of TA cells
into Matrigel using a range of concentrations and combinations of
serine proteinases and MMP inhibitors, including CT1746, TIMP-
1 and TIMP-2. TA cell invasion could only be slightly reduced by
high concentrations of MMP inhibitors and the serine protease
inhibitor aprotinin was more efficient. It has been shown previ-
ously that human mesothelioma expressed both the serine protease
urokinase-type plasminogen activator (uPA) and its receptor
(Shetty et al, 1995). Furthermore, Jeffers et al (1996b) reported
that HGF/SF enhanced tumourigenesis of sarcoma cell lines with
induction of the urokinase proteolysis network. Taken together
these data suggest that serine proteases, including uPA, could be
involved in HGF/SF-induced Matrigel invasion.
Our results highlight a major stimulatory effect of HGF/SF on
HMCL adhesion and invasion and the complex and disparate rela-
tionships between mesothelioma cell behaviour and MMP/TIMP
expression profiles. Further efforts should be made to better under-
stand the involvement of HGF/SF in the malignant behaviour of
HMCL, and in particular its impact on MMPs, serine proteinases
and adhesive proteins.
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